Sanara MedTech Inc.
SMTI- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0000714256
No open-market purchases or sales by Sanara MedTech Inc. insiders were filed in the last 90 days; 74 institutions reported holding it in 13F filings for Q2 2026, worth $42.1M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Sanara MedTech Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −2 vs. Q4 2021
- Shares held
- 275.4K
- −66.7K (−19.5%) vs. Q4 2021
- Total value
- $7.79M
- −$2.39M (−23.5%) vs. Q4 2021
- New holders
- 1
- 5 more added
- Sold out
- 3
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SMTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 74 | $42.1M |
| Q1 2026 | 65 | $25.6M |
| Q4 2025 | 53 | $45.2M |
| Q3 2025 | 58 | $36.1M |
| Q2 2025 | 53 | $31.4M |
| Q1 2025 | 49 | $28.3M |
| Q4 2024 | 51 | $31.6M |
| Q3 2024 | 44 | $24.5M |
| Q2 2024 | 40 | $20.6M |
| Q1 2024 | 43 | $25.1M |
| Q4 2023 | 47 | $28.2M |
| Q3 2023 | 43 | $19.8M |
| Q2 2023 | 47 | $26.7M |
| Q1 2023 | 35 | $19.1M |
| Q4 2022 | 31 | $17.4M |
| Q3 2022 | 28 | $9.94M |
| Q2 2022 | 21 | $5.45M |
| Q1 2022 | 21 | $7.79M |
| Q4 2021 | 23 | $10.2M |
| Q3 2021 | 24 | $13.1M |
| Q2 2021 | 21 | $9.72M |
| Q1 2021 | 20 | $17.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Sanara MedTech Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | +1 | New |
| Advisor Group Holdings, Inc. | 123 | $4.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 310 | $9.00K | 0.00% | +260+520.0% | Added |
| Lee Financial Co | 500 | $14.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 758 | $22.0K | 0.00% | +730+2,607.1% | Added |
| Lazard Asset Management LLC | 1,143 | $31.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,997 | $56.0K | 0.00% | −3,675−64.8% | Reduced |
| Rockefeller Capital Management L.P. | 5,500 | $156.0K | 0.00% | +1,000+22.2% | Added |
| New York State Common Retirement Fund | 5,747 | $159.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 8,013 | $222.0K | 0.00% | +613+8.3% | Added |
| BlackRock Inc. | 7,941 | $226.0K | 0.00% | −387−4.6% | Reduced |
| Salem Investment Counselors Inc | 11,210 | $319.0K | 0.01% | 00.0% | Unchanged |
| Laurion Capital Management LP | 14,589 | $405.0K | 0.01% | −10,458−41.8% | Reduced |
| Susquehanna International Group, LLP | 15,000 | $416.0K | 0.00% | −1,800−10.7% | Reduced |
| Captrust Financial Advisors | 14,768 | $421.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 16,624 | $473.0K | 0.02% | −599−3.5% | Reduced |
| Geode Capital Management, LLC | 24,583 | $682.0K | 0.00% | 00.0% | Unchanged |
| North Run Capital, LP | 24,000 | $684.0K | 1.01% | −41,000−63.1% | Reduced |
| Diametric Capital, LP | 30,330 | $863.0K | 0.48% | +968+3.3% | Added |
| Vanguard Group Inc | 92,198 | $2.63M | 0.00% | −313−0.3% | Reduced |
| Anson Funds Management LP | 0 | $0 | 0.00% | −9,097−100.0% | Sold out |
| Commons Capital, LLC | 0 | $0 | 0.00% | −2,043−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −905−100.0% | Sold out |